鲁抗医药：产品“盐酸伐地那非片”取得注册证

Group 1 - The core point of the article is that LuKang Pharmaceutical has received a drug registration certificate for its generic drug, Vardenafil Hydrochloride Tablets, from the National Medical Products Administration, indicating it has passed the consistency evaluation of quality and efficacy for generic drugs [2] - LuKang Pharmaceutical's revenue composition for the year 2024 is as follows: human antibiotics account for 54.29%, veterinary antibiotics account for 39.72%, other products account for 4.89%, and other business activities account for 1.1% [2]